Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (readOnly, idempotent, etc.), the description discloses concrete behaviors: pulls 10-K data from SEC EDGAR/XBRL for companies, handles off-calendar fiscal years, retrieves FAERS/FDA/trial counts for drugs, sorts by primary metric, and returns citation URIs. This is rich, useful context that annotations alone do not provide.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is concise but information-dense, with every sentence contributing new value: trigger phrases, data sources, fiscal-year handling, sorting, and return format. The opening phrase immediately anchors the tool's purpose, and the length is justified by the tool's complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple data sources, sorting, citations), the description covers all critical aspects: what it does, when to use it, what data it retrieves, how results are ordered, and what the output includes. No output schema exists, so the description carries the burden, and it does so thoroughly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

While the schema already covers both parameters, the description adds meaningful semantics: it explains what 'type' controls (company vs drug data sources) and what the 'values' array should contain for each type, with concrete examples. The schema_description_coverage is 100%, but the description goes beyond the schema by clarifying the data pulled and the sorting behavior.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: side-by-side comparison of 2–5 companies or drugs in a single parallel call. It explicitly contrasts with sequential single-pack lookups and includes trigger phrases ('X vs Y', 'which is bigger'), making it easy for an agent to recognize when to invoke it.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit when-to-use guidance via trigger examples and an 'ALWAYS PREFER' directive over sequential lookups. It also differentiates between company and drug modes, describing the data sources and metrics for each, so the agent knows exactly when this tool is the alternative to other tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation4/5

Most tools target distinct purposes (e.g., ask_pipeworx vs. get_repo vs. validate_claim), but there is some overlap between ask_pipeworx and ask_pipeworx_grounded, and between bet_research and polymarket_edges. Overall, an agent can generally distinguish them.

Naming Consistency2/5

Tool names lack a consistent pattern: some are verb_noun (search_repos, get_user), others are noun_verb (entity_profile), and many are compound descriptor phrases (polymarket_arbitrage, scan_dependency). This mixed convention makes the set feel disjointed.

Tool Count2/5

38 tools is excessive for a server named 'Github', especially since many tools (e.g., ai_visibility_check, bet_research) are unrelated to GitHub functionality. The count would be appropriate for a broader 'Pipeworx' server but not for a focused GitHub server.

Completeness2/5

The GitHub-relevant tools are limited to read-only operations (get_repo, list_commits, etc.), lacking essential actions like creating/updating repos, issues, or pull requests. The inclusion of numerous non-GitHub tools does not compensate for these gaps.